1. HCV and diabetes: towards a ‘sustained’ glycaemic improvement after treatment with DAAs? 
C. Fabrizio, A. Procopio 
Clinical Microbiology and Infection 
Volume 23, Issue 5, Pages (May 2017)
DOI: /j.cmi
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2. Fig. 1
Modification of fasting glucose (FG) levels during and after treatment. Dotted line shows trend of mean glycaemia levels. Bars represent percentage of patients with decrease of FG levels ≥20 mg/dL. Time points are expressed in weeks (w).
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions